Practically 60% of sufferers with IgAN within the SPARTAN Examine achieved full remission when utilizing FILSPARI as first-line therapy SPARTACUS Examine, PROTECT open-label extension,...
HAMILTON, Bermuda, Could 23, 2024 /PRNewswire/ -- Please discover enclosed the presentation of Flex (NASDAQ:) LNG Ltd.'s first quarter 2024 outcomes which might be...
